Connect with us

Medical Devices

MagVenture introduces new solution to improve the ease of use for non-invasive brain stimulation

Avatar

Published

on

ALPHARETTA, Ga., March 17, 2021 /PRNewswire/ — MagVenture, the Danish medical device company behind MagVenture TMS Therapy®, introduces the MagVenture Flow Arm — a patent pending*, clinical positioning system to optimize the delivery of MagVenture’s FDA cleared protocols for non-invasive brain stimulation technology within the treatment of major depressive disorder and as an adjunct therapy for OCD.

“Responsiveness to customer needs is a core part of MagVenture DNA,” says MagVenture SVP of Sales, Kerry Rome. “MagVenture is continuously striving to improve solutions to optimize the clinical practice of transcranial magnetic stimulation – or TMS in short. In recent years, the clinical market for TMS has expanded at such a rapid pace that manufacturers are being challenged to keep pace with the technological requirements emerging with the exponential expansion in the demand for utilization. We’ve seen MagVenture drive an FDA clearance for the ultra-fast ‘Theta Burst’ TMS which has reduced treatment times for patients from 37 to just 3 minutes. Now, with the introduction of a remarkedly smooth solution to help TMS operators quickly and easily prepare patients for treatment, MagVenture is further improving the efficiency and experience of TMS for patients and operators alike,” states Kerry Rome.

The latest improvement to the MagVenture TMS Therapy® system, deemed the ‘MagVenture Flow Arm’, concerns the applicator ‘coil’. The coil is essentially two very heavy spools of copper wire that produce and focus the magnetic fields for the non-invasive brain stimulation technique. The typically large and unwieldy coils, by necessity, have to be accurately positioned and held immobile over the brain target(s) during the TMS procedures. Over the past year, MagVenture product engineers and application experts, in close collaboration with MagVenture customers in the USA, Europe, Australia, and Asia, perfected a solution that vastly improves ease of use for MagVenture TMS operators to now, almost effortlessly, move and securely position TMS coils for non-invasive brain stimulation (TMS) procedures.

Kerry Rome goes on to add: “Throughout the R&D and testing phases for the Flow Arm project, the MagVenture organization here in the US has been waiting with much anticipation and, finally, we are super excited about the introduction of MagVenture’s patent-pending ‘Flow Arm’ for TMS coil positioning. It’s a game changer for TMS providers seeking optimal ease of use and efficiency in their clinical TMS services and, in context with the current COVID-19 pandemic, the improvements in the MagVenture reduced treatment/operator-patient interaction time is going to prove to be a big positive.”

Transcranial Magnetic Stimulation is a technology that applies rapidly changing magnetic fields to stimulate specific areas in the brain. TMS has been available as a tool for non-invasive brain stimulation for more than three decades and is currently used extensively in clinical psychiatry, and for ongoing academic medical and translational neuroscience research. MagVenture TMS Therapy® is FDA cleared as a treatment for major depressive disorder (MDD) and as an adjunct therapy treatment for obsessive-compulsive disorder (OCD). MagVenture TMS Therapy® is an outpatient procedure with a well-tolerated safety profile with no systemic side effects. The most common side effects are headaches and nausea. MagVenture TMS Therapy® has been clinically available in the USA since 2015 and is currently delivered at hospitals and psychiatric practices nationwide.

Contact details: Kerry Rome, Vice President Sales, MagVenture Inc., USA: 310 213 2697, email: kr@magventure.com

MagVenture TMS Therapy® FDA clearances: “Treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode and as an “adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD)”.

MagVenture is a Danish medical device company specializing in non-invasive magnetic stimulation solutions for the clinical treatments and brain research. In 2018, MagVenture was the first TMS company to receive FDA clearance for Express TMS®, reducing treatment time from the standard 37 minutes to just 3 minutes per session.

MagVenture A/S has over 25 years of experience within neuromodulation. From its headquarters in Denmark, MagVenture’s products are manufactured and promoted worldwide through direct sales subsidiaries in the US, Brazil, Germany, the UK, and through an extensive global network of dedicated distributors in Europe, Asia, Middle East, and the Americas.

* Pat. EP 20214073.7 / US 63/125,594.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/magventure-introduces-new-solution-to-improve-the-ease-of-use-for-non-invasive-brain-stimulation-301247530.html

SOURCE MagVenture

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.biospace.com/article/releases/magventure-introduces-new-solution-to-improve-the-ease-of-use-for-non-invasive-brain-stimulation/?s=93

Medical Devices

New York Bone & Joint Specialists: New Invention Stops or Delays the Progression of Osteoarthritis of the Knee

Avatar

Published

on

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://infomeddnews.com/new-york-bone-joint-specialists/

Continue Reading

Medical Devices

Ping An AskBob Doctor’s Smart Imaging Model for Diagnosis of Pelvic and Hip Injuries is a Breakthrough for Artificial Intelligence

Avatar

Published

on

April 1, 2021

Ping An Insurance (Group) Company of China, Ltd. “Ping An” announced that Ping An AskBob Doctor’s smart imaging model for diagnosing pelvic and hip injuries is the first of its kind to accurately detect all kinds of trauma-related findings simultaneously in X-ray images.

In a research paper published in the international journal Nature Communications, the model is shown to overcome the limitation of other artificial intelligence (AI) systems, which can only detect individual fractures.

The model, a deep learning algorithm, can help physicians make faster, more accurate diagnoses and save lives. Hip fractures mainly occur in elderly people and patients with major trauma. Although they are not directly fatal, complications can lead to a high mortality rate. Reducing the rate of missed diagnoses, improving the comprehensiveness of the detection, and providing accurate diagnoses is critical.

Ping An Health Technology Research Institute, Ping An Smart City, Ping An Good Doctor and the Department of Trauma and Emergency Surgery of Chang Gung Memorial Hospital in Taiwan jointly released the research paper “A scalable physician-level deep learning algorithm detects universal trauma on pelvic radiographs”. The research team gathered the pelvic X-ray data of 1,888 emergency room patients to evaluate the model’s performance in obtain the fracture results and locations. It achieved an overall accuracy of 92.4%. Compared with general clinical diagnoses, the model substantially improves detection accuracy, speeds up the treatment progress, improves the treatment effectiveness on high-risk patients, and reduces the economic cost to patients through earlier detection and treatment.

This is the first AI algorithm to detect all fracture types captured on the X-ray images, including, but not limited to, hip fractures, pelvic fractures, femoral fractures, hip dislocation and artificial joint peripheral fractures.

As of March, 2021, the AskBob Doctor AI pelvic trauma detection technology has been used in the real-life clinical environment in Chang Gung Memorial Hospital in Taiwan for nearly eight months. The results have shown that the misdiagnosis rate has significantly reduced. Since adopting the AI system, the misdiagnosis rate has dropped from 9.7% to 0.7% among emergency physicians, 11.3% to 1.58% among resident physicians and 6% to 0.5% among specialist physicians. The model has performed comparably to radiologists and certain orthopedic specialists in terms of quantitative indicators such as sensitivity and specificity.

The smart imaging model for the diagnosis of pelvis and hip injuries is Ping An’s latest achievement in smart imaging technology. Ping An’s smart imaging technology covers nine major systems of human body — the motor, digestive, respiratory, urinary, reproductive, endocrine, immune, nervous and cardiovascular systems. It supports various equipment including computed tomography (CT,) X-ray, ultrasound and fundus optical coherence tomography (OCT).

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://infomeddnews.com/ping-an-askbob-doctors-smart-imaging-model/

Continue Reading

Medical Devices

Sander de Vos Is Appointed Chief Business Officer of IME Medical

Avatar

Published

on

April 1, 2021

Sander de Vos will be responsible for the worldwide roll-out of the company’s medical electrospinning strategy, based on IME’s ground-breaking MediSpin™XL industrial production platform.

Judith Heikoop, CEO of IME Medical Electrospinning said, “We at IME are thrilled to welcome Sander to our fast-growing team of professionals. Sander clearly brings a wealth of well-needed life science experience into the company, that will certainly be of key-value to the further development of our electrospun medical device franchises. Our aim is to become the first partner of choice worldwide for the development of a novel, groundbreaking class of medical devices and pharma products based on nanofibers. Our ever-growing portfolio of customers and partners includes the Medtech and Pharma industry, universities, hospitals, and medical institutes.”

Sander de Vos (46) is an accomplished executive with more than 15 years of leadership experience across healthcare and biotech commercial and business development positions. Prior to joining IME, Sander worked at Mimetas, an innovative Dutch start-up company providing novel human cell biology models for improved therapies, where he played a key role in expanding the collaborations with its pharma and biotech partners.

In previous roles, Sander led the commercial team of Isogen Life Science and acquired experience as an entrepreneur growing a private business. His commercial career started at Westburg Life Sciences and for more than 10 years he shaped and directed the sales strategy and commercial development of part of their life science business.

Sander has a background in molecular biology, co-developed a molecular diagnostic test for simultaneous detection of tick-borne pathogens, and contributed to the development of a vaccine against ticks at the Faculty of Veterinary Medicine of the Utrecht University.

Sander de Vos, Chief Business Officer of IME Medical Electrospinning, said: “With the potential of becoming the global leader in large-scale production of best-in-class nanofiber based medical devices and drug delivery solutions, I’m proud, gratified and delighted to become a member of the IME management team. The company’s technology enables faster and better recovery of tissues and body structures, and therefore IME is uniquely positioned to make a meaningful difference in the lives of patients.”

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://infomeddnews.com/sander-de-vos-ime-medical/

Continue Reading

Medical Devices

Dipti Itchhaporia, MD, FACC: New American College of Cardiology President

Avatar

Published

on

April 1, 2021

Dipti Itchhaporia, MD, FACC, today begins her term as president of the American College of Cardiology.

During her one-year presidency, she will lead the over 54,000-member global organization in its mission to transform cardiovascular care and improve heart health.

“From the moment I became a Fellow of the ACC, I’ve been excited about being a part of this community and contributing to advancing the field of cardiology and the patients we serve,” Itchhaporia said. “I’m looking forward to connecting the cardiovascular community over the next year, as we emerge from a mostly virtual world, to make strides in our strategic priorities and improve the lives of heart disease patients. We must be prepared as a profession to embrace and move to center stage our solutions and vision of digital transformation and health equity.”

Itchhaporia is an interventional cardiologist who is the Eric and Sheila Samson Endowed Chair in Cardiovascular Health, director of disease management for Hoag’s Jeffrey M. Carlton Heart and Vascular Institute in Newport Beach, California, and associate professor of medicine at the University of California, Irvine. She has been a leader in the College for over 20 years, previously holding positions both nationally and in the ACC California Chapter.

Most recently, Itchhaporia held the position of ACC vice president. She previously served as a member of the ACC’s Board of Trustees and the Board of Governors, secretary of the ACC as chair of the Board of Governors, and president of the ACC California Chapter. She has also served on multiple ACC committees and helped to advance the College’s education, science and innovation efforts, including as a member of the ACC Lifelong Learning Oversight Committee, Science and Quality Committee, Governance Committee, Practice Administrator Workgroup and as an advisor for the ACC’s Innovation Program.

Itchhaporia’s professional interests include quality measurement and improvement in cardiovascular disease, focusing on emerging risk factors and medical and lifestyle interventions to prevent coronary heart disease. She is also extensively involved in advancing technology and innovations that will advance the digital transformation of cardiovascular medicine to ultimately improve the lives of patients and clinicians, while helping to achieve health equity.

Itchhaporia’s professional passions have led to leadership roles in advancing the ACC’s strategic priorities, including serving as chair of the ACC Board of Trustees Health Equity Task Force, which addresses issues of health disparities, the social determinants of health and improving access to care for underserved patients. Further work toward health equity will be at the forefront of her presidential year.

“Health equity has been a priority for the College for a long time and for the first time we are feeling like this could be actualized,” Itchhaporia said. “In cardiology we need to have the mindset to prioritize health equity issues, and I’m excited that this is in our reach.”

She received her medical degree from St. Louis University School of Medicine and completed her residency in internal medicine at Stanford University Medical Center. She then joined the general medicine faculty at the University of California, San Francisco (UCSF), ultimately pursuing a cardiology fellowship at Georgetown University and an interventional cardiology fellowship at Stanford University.

Other ACC officers for 2021-2022 are Vice President Edward T. A. Fry, MD, FACC; Board of Governors Chair Joseph Marine, MD, FACC; and Treasurer Christopher M. Kramer, MD, FACC.

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://infomeddnews.com/dipti-itchhaporia-president-acc/

Continue Reading
Esports4 days ago

chessbae removed as moderator from Chess.com amid drama

Esports3 days ago

DreamHack Online Open Ft. Fortnite April Edition – How To Register, Format, Dates, Prize Pool & More

Esports4 days ago

Why did Twitch ban the word “obese” from its predictions?

Esports3 days ago

Hikaru Nakamura drops chessbae, apologizes for YouTube strike

Fintech3 days ago

Australia’s Peppermint Innovation signs agreement with the Philippine’s leading micro-financial services provider

Esports5 days ago

Dota 2: Team Nigma Completes Dota 2 Roster With iLTW

Esports4 days ago

Hikaru Nakamura accused of striking Eric Hansen’s YouTube channel

Esports4 days ago

Fortnite: Blatant Cheater Finishes Second In A Solo Cash Cup

Esports5 days ago

LoL: Blaber Named 2021 LCS Spring Split Honda MVP

Esports4 days ago

Twitch bans Adin Ross after ZIAS uses Homophobic slurs during his stream

Blockchain5 days ago

Bitcoin Kurs durchbricht 60.000 USD-Marke

Esports4 days ago

LoL: LCS MSS Lower Bracket Finals Recap- Team Liquid vs TSM

Esports4 days ago

The best way to play Hecarim in League of Legends season 11

Esports5 days ago

LoL: Rekkles Named 2021 LEC Spring Split MVP

Esports5 days ago

Broodmother reworked, Necronomicon removed in 7.29 update

Esports4 days ago

Atlanta FaZe advance to the Grand Finals at the Stage 2 Major by defeating Dallas

Esports4 days ago

Ludwig has announced when he’ll end his subathon Twitch stream

Esports3 days ago

Coven and Abomination highlight the new TFT Reckoning Traits

Blockchain5 days ago

Ethereum Preis erreicht neues Allzeithoch bei 2200 USD

Esports5 days ago

LoL: LEC 2021 Spring Lower Bracket Finals Recap- G2 Esports vs Rogue

Trending